Testing effectiveness (Phase 2)Study completedNCT02629419
What this trial is testing
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Who this might be right for
Candidiasis, Chronic Mucocutaneous
Matinas BioPharma Nanotechnologies, Inc. 4
Showing 5 of 5 results